Bristol-Myers Squibb Co  

(Public, NYSE:BMY)   Watch this stock  
Find more results for BMY
+0.16 (0.29%)
After Hours: 56.33 +0.13 (0.23%)
Mar 28, 7:57PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 55.93 - 56.37
52 week 46.01 - 77.12
Open 56.04
Vol / Avg. 8.53M/11.81M
Mkt cap 92.84B
P/E 21.15
Div/yield 0.39/2.78
EPS 2.66
Shares 1.67B
Beta 1.09
Inst. own 72%
Jan 26, 2017
Q4 2016 Bristol-Myers Squibb Co Earnings Call
Jan 26, 2017
Q4 2016 Bristol-Myers Squibb Co Earnings Release
Jan 10, 2017
Bristol-Myers Squibb Co at JPMorgan Healthcare Conference
Jan 5, 2017
Bristol-Myers Squibb Co at Goldman Sachs CEOs Unplugged Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 17.13% 23.20%
Operating margin 21.51% 30.84%
EBITD margin - 30.93%
Return on average assets 10.68% 13.77%
Return on average equity 22.56% 29.28%
Employees 25,000 -
CDP Score - 100 C


NEW YORK, NY 10154
United States - Map
+1-212-5464000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.

Officers and directors

Giovanni Caforio M.D. Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Charles A. Bancroft Chief Financial Officer and Executive Vice President - Global Business Operations
Age: 57
Bio & Compensation  - Reuters
Louis S. Schmukler President - Global Manufacturing and Supply
Age: 61
Bio & Compensation  - Reuters
Ann Powell Judge Chief Human Resource Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Thomas J. Lynch Jr., M.D., Ph.D. Executive Vice President, Chief Scientific Officer
Age: 56
Bio & Compensation  - Reuters
Sandra Leung Executive Vice President, General Counsel
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Murdo Gordon Executive Vice President, Chief Commercial Officer
Age: 50
Bio & Compensation  - Reuters
Paul von Autenried Senior Vice President - Enterprise Services, Chief Information Officer
Age: 55
Bio & Compensation  - Reuters
Anne Nielsen Senior Vice President, Chief Compliance and Ethics Officer
Age: 56
Bio & Compensation  - Reuters
Joseph C. Caldarella Senior Vice President, Corporate Controller
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance